Hugging Face is too important to fall into Nvidia's hands

Nvidia agreed to buy Hugging Face for $12.9B, expected to close next year, but the opinion argues regulators should block it due to major antitrust/competition concerns. The piece highlights Hugging Face as a central open-source AI model repository and infrastructure (“AI Switzerland”), warning Nvidia could steer documentation, software, and compute toward its own stack and away from competitors. While Hugging Face CEO cites user growth from ~18M to 100M, the article frames the deal as likely to harm competition despite Nvidia’s assurances.

Analysis

The market mechanism is less about the deal value and more about control of the developer distribution layer. If NVDA can influence where models are documented, benchmarked, and deployed first, it raises the switching cost for inference stacks that are trying to stay hardware-agnostic, which is the real threat to AMD: not lost today’s revenue, but slower adoption of its software ecosystem and weaker default status with builders over 6-18 months.

Near term, this is primarily a regulatory event, not a fundamental one. A credible antitrust challenge would create a 1-3 month overhang on NVDA’s multiple because investors will price in both execution delay and the risk of behavioral remedies that blunt cross-selling; if the deal is blocked, the market likely treats it as a contained headline washout rather than a earnings hit. The key second-order loser is any “neutral” AI platform that competes on openness; once a dominant chip vendor owns the layer where developers congregate, rivals must spend more on subsidies, documentation, and incentives to preserve share.

Contrarian view: consensus may be underestimating how little near-term P&L this changes. Even if approved, the first-order revenue contribution is immaterial; the real value is strategic optionality, so the stock reaction can overshoot on antitrust fear. What would falsify the bearish thesis is an early, credible commitment to maintain independent governance, data neutrality, and open partner access, or a clean regulatory path that signals the acquisition will not constrain competing accelerators.

Key Decisions for Investors

• Trade the regulatory spread: short NVDA / long AMD for the next 4-8 weeks. Thesis is that NVDA faces a larger antitrust multiple discount than AMD, while AMD benefits from any developer backlash toward platform neutrality. Cover if NVDA closes above the pre-announcement high and regulators signal no action.
• Buy AMD Jan-2026 call spreads rather than outright calls. Risk/reward is better if the market starts to reprice software share gains and incremental accelerator substitution over 6-12 months, but the position should be sized as a slow-burn optionality trade, not a catalyst bet.
• Use NVDA put spreads around the next regulatory milestone only if implied vol stays below realized. The edge is event-driven: downside should show up on DOJ/FTC process headlines, while upside is capped if the deal is framed as benign. Exit if there is no formal challenge within 30-45 days.
• Set an alert on AMD relative strength versus NVDA. If AMD underperforms on a blocked-deal outcome, it suggests the market is still pricing broader AI demand, not competitive share loss; if AMD outperforms on scrutiny headlines, that supports the neutrality thesis and argues for adding to the pair.